| Recruitment status | Open public recruiting |
| Unique ID issued by UMIN | UMIN000043607 |
| Receipt No. | R000049784 |
| Scientific Title | Analgesic effects of ultrasound-guided maxillary nerve block and inferior alveolar nerve block for upper and lower orthognathic surgery: a randomized controlled trial |
| Date of disclosure of the study information | 2021/03/13 |
| Last modified on | 2021/07/19 (Ver. 3) |
| Basic information | ||
| Public title | Analgesic effects of ultrasound-guided maxillary nerve block and inferior alveolar nerve block for upper and lower orthognathic surgery: a randomized controlled trial | |
| Acronym | Analgesic effects of ultrasound-guided maxillary nerve block and inferior alveolar nerve block for upper and lower orthognathic surgery | |
| Scientific Title | Analgesic effects of ultrasound-guided maxillary nerve block and inferior alveolar nerve block for upper and lower orthognathic surgery: a randomized controlled trial | |
| Scientific Title:Acronym | Analgesic effects of ultrasound-guided maxillary nerve block and inferior alveolar nerve block for upper and lower orthognathic surgery | |
| Region |
|
|
| Condition | |||||
| Condition | vertical jaw deformities | ||||
| Classification by specialty |
|
||||
| Classification by malignancy | Others | ||||
| Genomic information | NO | ||||
| Objectives | |
| Narrative objectives1 | In this study, we will evaluate the safety of ultrasound-guided maxillary nerve block and inferior alveolar nerve block in patients undergoing vertical jaw deformities by measuring blood levels of local anesthetics and randomly assigning subjects to the block group and the control group who will not undergo block intervention. We evaluate the effects on the number of analgesics required (primary outcome), pain score, analgesic effect, and quality of postoperative recovery (secondary outcome) for 24 hours after the block. The purpose of this study is to establish a safe and effective analgesic method for orthognathic surgery. |
| Basic objectives2 | Safety,Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | Confirmatory |
| Trial characteristics_2 | |
| Developmental phase | Not applicable |
| Assessment | |
| Primary outcomes | The number of times rescue analgesics are used in the 24 hours following the block. |
| Key secondary outcomes | After the block (1, 5, 15, 30, 60 min), levobupivacaine blood level, NRS at/after return, intraoperative opioid (fentanyl, remifentanil) use, pre-/postoperative QoR-40 scores, time to first analgesic use after discharge, complications of ner ve block (local anesthetic systemic toxicity, hematoma, local infection), respiratory complications in the first 24 hours after surgery |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Parallel |
| Randomization | Randomized |
| Randomization unit | Individual |
| Blinding | Single blind -participants are blinded |
| Control | No treatment |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | Institution is not considered as adjustment factor. |
| Blocking | |
| Concealment | |
| Intervention | |||
| No. of arms | 2 | ||
| Purpose of intervention | Treatment | ||
| Type of intervention |
|
||
| Interventions/Control_1 | In the block group, bilateral ultrasound-guided maxillary and inferior alveolar nerve blocks are performed after induction of general anesthesia, and 5 mL each of 0.375% levobupivacaine is administered for a total of 20 mL. The time at which all four nerve blocks are completed is set as 0 minutes, and arterial blood samples are collected at 1, 5, 15, 30, and 60 minutes to measure the blood concentration of levobupivacaine. | ||
| Interventions/Control_2 | In the control group, no block intervention was performed and no arterial blood sampling was done. | ||
| Interventions/Control_3 | |||
| Interventions/Control_4 | |||
| Interventions/Control_5 | |||
| Interventions/Control_6 | |||
| Interventions/Control_7 | |||
| Interventions/Control_8 | |||
| Interventions/Control_9 | |||
| Interventions/Control_10 | |||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | over 16 years of age
ASA-PS I to III undergoing upper and lower jaw plastic surgery |
|||
| Key exclusion criteria | Patients who are allergic to the study drug, blood coagulation disorders, chronic opioid use, pregnancy, mental disorders, patients who were not extubated in the operating room after surgery for some reason, and other patients who, at the discretion of the physician in charge, are considered inappropriate for this study. | |||
| Target sample size | 40 | |||
| Research contact person | |||||||
| Name of lead principal investigator |
|
||||||
| Organization | Sapporo Medical University School of Medicine | ||||||
| Division name | Department of Anesthesiology | ||||||
| Zip code | 0608543 | ||||||
| Address | S1W16, Chuo-ku, Sapporo, Hokkaido | ||||||
| TEL | 011-688-9663 | ||||||
| michiaki_yamakage@icloud.com | |||||||
| Public contact | |||||||
| Name of contact person |
|
||||||
| Organization | Sapporo Medical University School of Medicine | ||||||
| Division name | Department of Anesthesiology | ||||||
| Zip code | 0608543 | ||||||
| Address | S1W16, Chuo-ku, Sapporo, Hokkaido | ||||||
| TEL | 011-688-9663 | ||||||
| Homepage URL | |||||||
| todonotumari@me.com | |||||||
| Sponsor | |
| Institute | Sapporo Medical University Hospital |
| Institute | |
| Department | |
| Funding Source | |
| Organization | none |
| Organization | |
| Division | |
| Category of Funding Organization | Other |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | Kitami Japanese Red Cross Hospital |
| Name of secondary funder(s) | |
| IRB Contact (For public release) | |
| Organization | Sapporo Medical University Hospital Institutional Review Board |
| Address | S1W16, Chuo-ku, Sapporo, Hokkaido |
| Tel | 011-611-2111 |
| kouhou-byouin@sapmed.ac.jp | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | 札幌医科大学附属病院(北海道),北見赤十字病院(北海道) |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| Result | |
| URL related to results and publications | |
| Number of participants that the trial has enrolled | |
| Results | |
| Results date posted | |
| Results Delayed | |
| Results Delay Reason | |
| Date of the first journal publication of results | |
| Baseline Characteristics | |
| Participant flow | |
| Adverse events | |
| Outcome measures | |
| Plan to share IPD | |
| IPD sharing Plan description | |
| Progress | |||||||
| Recruitment status | Open public recruiting | ||||||
| Date of protocol fixation |
|
||||||
| Date of IRB |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Other | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000049784 |